The Prognostic Importance of Isolated Tumor Cell Clusters and Micrometastases in Sentinel Lymph Nodes

REFERENCES

• Nemoto T., Vana J., Bedwani R. N., et al. Management and survival of female breast cancer: results of a national survey by the American College of Surgeons. Cancer 1980; 45: 2917–2924
   PubMed Web of Science ®Google Scholar
• Huvos A. G., Hutter R. V.P., Berg J W. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 1971; 173: 44–46
   PubMed Web of Science ®Google Scholar
• Greene F. L., Page D. L., Fleming I. D., et al. Breast AJCC Cancer Staging Manual. 6th ed. Springer, New York 2002
   Google Scholar
• UICC TNM Classification of Malignant Tumours, 6th ed, L. H. Sobin, Ch Wittekind. John Wiley and Sons, New York 2002
   Google Scholar
• Singletary S. E., Greene F. L., Sobin L. H. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003; 98: 2740–2741
   PubMed Web of Science ®Google Scholar
• Al-Hajj M., Wicha M. S., Benito-Hernandez A., Morrison S. J., Clarke M. F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3547–3549
   PubMedGoogle Scholar
• Dontu G., Al-Hajj M., Abdallah W. M., Clarke M. F., Wicha M. S. Stem cells in normal breast development and breast cancer. Cell Prolif 2003; 36(1)59–72
   PubMedGoogle Scholar
• Braun S., Cevatli B. S., Assemi C., et al. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy. J Clin Oncol 2001; 19: 1468–1475
   PubMed Web of Science ®Google Scholar
• Fitzgibbons P. L., Page D. L., Weaver D., et al. Prognostic factors in breast cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000; 124: 966–978
   PubMed Web of Science ®Google Scholar
• Lyman G. H., Giuliano A. E., Somerfield M. R., et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005; 23(30)7703–7720
   PubMed Web of Science ®Google Scholar
• Weaver D. L. Sentinel lymph nodes and breast carcinoma: which micrometastases are clinically significant?. Am J Surg Pathol 2003; 27: 842–845
   PubMed Web of Science ®Google Scholar
• Carter C. L., Allen C., Henson D. Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 1989; 63: 181–187
   PubMed Web of Science ®Google Scholar
• Fisher E., Palekar A., Rockette H., Redmond C., Fisher B. Pathologic findings from the national surgical adjuvant breast project (Protocol No. 4): V. significance of axillary nodal micro- and macrometastases. Cancer 1978; 42: 2032–2038
   PubMed Web of Science ®Google Scholar
• Weaver D. L. Pathological evaluation of sentinel lymph nodes in breast cancer: a practical academic perspective from America. Histopathology 2005; 46: 702–706
   PubMedGoogle Scholar
• Carter B. A., Jensen R. A., Simpson J. F., Page D. L. Benign transport of breast epithelium into axillary lymph nodes after biopsy. Am J Clin Pathol 2000; 113: 259–265
   PubMed Web of Science ®Google Scholar
• Moore K. H., Thaler H. T., Tan L. K., Borgen P. I., Cody H. S., III. Immunohistochemically detected tumor cells in the sentinel lymph nodes of patents with breast carcinoma: biologic metastasis or procedural artifact?. Cancer 2004; 100: 929–934
   PubMed Web of Science ®Google Scholar
• Hansen N. M., Ye X., Grube B. J., Giuliano A. E. Manipulation of the primary breast tumor and the incidence of sentinel node metastases from invasive breast cancer. Arch Surg 2004; 139: 634–640
   PubMed Web of Science ®Google Scholar
• Lara J. F., Young S. M., Velilla R. E., Santoro E. J., Templeton S. F. The relevance of occult axillary micrometastases in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up. Cancer 2003; 98: 2105–2113
   PubMed Web of Science ®Google Scholar
• Michaelson J. S., Silverstein M., Sgroi D., et al. The effect of tumor size and lymph node status on breast carcinoma lethality. Cancer 2003; 98: 2133–2143
   PubMed Web of Science ®Google Scholar
• Weaver D. L., Krag D. N., Ashikaga T., Harlow S. P., O'Connell M. Pathologic analysis of sentinel and non-sentinel lymph nodes in breast carcinoma: a multicenter study. Cancer 2000; 88: 1099–1107
   PubMed Web of Science ®Google Scholar
• Hermanek P., Hutter R. V., Sobin L. H., Wittekind C. International Union against cancer. classification of isolated tumor cells and micrometastasis. Cancer 1999; 86: 2668–2673
   PubMed Web of Science ®Google Scholar
• Saphir O., Amromin G. D. Obscure axillary lymph node metastases in carcinoma of the breast. Cancer 1948; 1: 238–241
   PubMed Web of Science ®Google Scholar
• Dowlatshahi K., Fan M., Snider H. C., Habib F. A. Lymph node micrometastases from breast carcinoma: reviewing the dilemma. Cancer 1997; 80: 1188–1197
   PubMed Web of Science ®Google Scholar
• Krag D. N., Julian T. B., Harlow S. P., et al. NSABP-32: phase III randomized trial comparing axillary resection with sentinel lymph node dissection: a description of the trial. Ann Surg Oncol 2004; 11(3)208s–210s
   PubMed Web of Science ®Google Scholar
• Harlow S. P., Krag D. N., Julian T. B., et al. Prerandomization surgical training for the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-32 trial: a randomized phase III clinical trial to compare sentinel node resection to conventional axillary dissection in clinically node-negative breast cancer. Ann Surg 2005; 241: 48–54
   PubMed Web of Science ®Google Scholar
• Cserni G., Amendoeira I., Apostolikas N., et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey of the European Working Group for Breast Screening Pathology. J Clin Pathol 2004; 57: 695–701
   PubMed Web of Science ®Google Scholar